Jaundice and antibodies directed against factors 8 and 9 in patients treated for haemophilia or Christmas disease in the United Kingdom.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000906:Antibodies; D000917:Antibody Formation; D000937:Antigen-Antibody Reactions; D002648:Child; D002675:Child, Preschool; D003450:Cryoglobulins / Q000009:adverse effects / Q000627:therapeutic use; D005164:Factor IX; D005169:Factor VIII; D006467:Hemophilia A / Q000150:complications* / Q000276:immunology / Q000628:therapy; D002836:Hemophilia B / Q000150:complications* / Q000276:immunology / Q000628:therapy; D006515:Hepatitis B virus; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007565:Jaundice / Q000150:complications* / Q000453:epidemiology; D008875:Middle Aged
D000906:Antibodies; D003450:Cryoglobulins; D005169:Factor VIII; D005164:Factor IX